Active Surveillance for Cancer Doesn’t Increase Malpractice RiskApril 1, 2024Genitourinary CancerBreast CancerLung CancerMelanomaAMLBusiness of MedicineMixed Topics
Extraordinary Patients Inspired Father of Cancer ImmunotherapyMarch 19, 2024Mixed TopicsMelanomaLung CancerImmuno-oncologyGenitourinary CancerBreast CancerAML
Unleashing Our Immune Response to Quash CancerFebruary 21, 2024Immuno-oncologyMixed TopicsAMLMultiple MyelomaDiversity in MedicineBusiness of MedicineBreast Cancer
FDA panel voices concerns over 2 lymphoma accelerated approvalsNovember 17, 2023Mixed TopicsAMLMultiple Myeloma
ESMO helps hematologists assess new cancer drugsJune 28, 2023Mixed TopicsAMLMultiple MyelomaMyelodysplastic Syndrome
Multiprong strategy makes clinical trials less WhiteJune 23, 2023Diversity in MedicineBreast CancerGenitourinary CancerMelanomaAMLMultiple MyelomaMyelodysplastic Syndrome
CBSM phone app eases anxiety, depression in cancer patientsJune 23, 2023Breast CancerGenitourinary CancerLung CancerMelanomaAMLMultiple MyelomaMyelodysplastic Syndrome
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Breast CancerGenitourinary CancerLung CancerMelanomaAMLMultiple MyelomaMyelodysplastic Syndrome
